Literature DB >> 2420348

Hypotension in response to iloprost, a prostacyclin analogue.

J W Upward, H A Strong, C F George, B C Ogilive, V Challenor, N Conway.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2420348      PMCID： PMC1400910          DOI： 10.1111/j.1365-2125.1986.tb05184.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  3 in total

1.  THE AGGREGATION OF BLOOD PLATELETS.

Authors:  G V BORN; M J CROSS
Journal:  J Physiol       Date:  1963-08       Impact factor: 5.182

2.  Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man.

Authors:  H Pickles; J O'Grady
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

3.  Early and late administration of a PGI2-analogue, ZK 36 374 (iloprost): effects on myocardial preservation, collateral blood flow and infarct size.

Authors:  E F Smith; W Gallenkämper; R Beckmann; T Thomsen; G Mannesmann; K Schrör
Journal:  Cardiovasc Res       Date:  1984-03       Impact factor: 10.787
  3 in total
  3 in total

1.  Intravenous infusion of iloprost in arterial occlusive disease: dose-dependent effects on skin microcirculation.

Authors:  L Caspary; A Creutzig; K Alexander
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 2.  Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures.

Authors:  S M Grant; K L Goa
Journal:  Drugs       Date:  1992-06       Impact factor: 9.546

Review 3.  Fundamentals of aerosol therapy in critical care.

Authors:  Jayesh Dhanani; John F Fraser; Hak-Kim Chan; Jordi Rello; Jeremy Cohen; Jason A Roberts
Journal:  Crit Care       Date:  2016-10-07       Impact factor: 9.097
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.